Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Targeting non-invasive treatment for cardiac amyloidosis
Targeting non-invasive solution to treating cardiac amyloidosis
Key learnings from the Tmem65 protein
Identifying its key role in gap junction biology
Closing the literal gap on dangerous arrhythmia
Microinjection system with off-the-charts efficiency